Bausch & Lomb Corp (BLCO) — SEC Financial Statements & Analysis

Bausch & Lomb Corp (BLCO) is a ophthalmic goods company. Bausch & Lomb Corp trades on NYSE as: BLCO. Bausch & Lomb Corp (BLCO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, Bausch & Lomb Corp carries a market cap of $5.91B, a P/E ratio of -36.28x, a P/B ratio of 0.92x, a P/S ratio of 1.11x, an enterprise value of $5.54B, and an EV/EBITDA multiple of 7.54x. On profitability, it posts a gross margin of 61.50%, an operating margin of 6.07%, a net margin of -3.06%, a Return on Equity (ROE) of -2.52%, a Return on Assets (ROA) of -1.18%, and a Return on Invested Capital (ROIC) of 0.00%. Per share, it reports EPS of $-0.46, diluted EPS of $-0.46, free cash flow per share of $0.38, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 8.85% year-over-year, net income growth of -38.26% year-over-year, and EPS growth of -38.85% year-over-year. On the balance sheet, it maintains a current ratio of 1.55x, a quick ratio of 0.81x, working capital of $1.03B, a debt-to-equity ratio of 1.15x, a debt ratio of 0.54, an interest coverage ratio of 0.83x, free cash flow of $137.00M (TTM), and net debt of $-378.00M. Figures sourced from SEC EDGAR.

Market Cap

$5.91B

P/E TTM

-36.28x

EPS TTM

$-0.46

P/B TTM

0.92x

ROE TTM

-2.52%

ROA TTM

-1.18%

Debt To Equity

1.15x

Free Cash Flow TTM

$137.00M

Net Revenue TTM Growth 1Y

8.85%

Data as of 2026-06-30 · Source: SEC EDGAR